- Blog
- News & Media
- Issues
- About The Biopharmaceutical Sector
- Access and Affordability
- Adherence
- Appropriate Use Of Medicines
- Counterfeit Drugs
- Disaster Response
- Drug Safety
- Environmental Issues
- Food And Drug Administration
- Importation
- Intellectual Property
- International
- Medical Advances
- Medicare
- Prescription Drug Abuse
- Prescription Drug User Fee Act
- Sales And Marketing
- Research
- About
Will an inspirational SOTU lead to action?
by Jenni Brewer on 1/25/2012
President Obama's State of the Union address and its focus on jobs comes at a time when America's biopharmaceutical research sector is developing nearly 3,000 medicines and bringing new treatment options to patients in need today -- all while supporting high-value jobs. Remarkable innovation is underway. Good American jobs are being created. But this progress can't continue if policies don't embrace the work (see PhRMA President John Castellani’s statement on Tuesday night’s SOTU).
President Obama's speech was inspiring. I'd be hard pressed to find someone who didn't agree with the need to generate more American jobs and spur American innovation. Now I'm on the lookout for action -- policies that back these aspirations and support innovative sectors of our economy, such as the biopharmaceutical research industry.
By submitting, you agree to PhRMA's Terms of Use.



